2004•中国医师杂志Requires access

A Clinical Study on the Anticoagulant Treatment of Pre-thrombosis State in Patients with Cor Pulmonale

赵建华, 冯孟森, 王倩, 赵文玲

Open publisher page 0 citations

Abstract

目的 探讨肺心病患者的血栓前状态,观察并分析低分子肝素抗凝干预的疗效.方法将54例肺心病患者分为低分子肝素治疗组和常规治疗组各27例,分别检测治疗前后血浆血管性假血友病因子(VWF)、血浆凝血酶片段1+2(F1+2)、纤维蛋白原(Fg)、血小板颗粒膜蛋白(GMP-140)和D一二聚体(DD).结果肺心病患者VWF、F1+2、Fg、GMP-140、DD血浆浓度显著高于对照组;肺心病治疗组经LMWH治疗后上述各凝血分子标记物及PaCO2明显降低,而PaO2显著增高,常规组虽血气指标略有改善,但凝血分子标记物未见改善.结论尽早检测肺心病血栓前状态,及时给予低分子肝素抗凝干预,有望从根本上改善肺心病急性加重期患者的不良预后。

About this research paper

What this paper is about

目的 探讨肺心病患者的血栓前状态,观察并分析低分子肝素抗凝干预的疗效.方法将54例肺心病患者分为低分子肝素治疗组和常规治疗组各27例,分别检测治疗前后血浆血管性假血友病因子(VWF)、血浆凝血酶片段1+2(F1+2)、纤维蛋白原(Fg)、血小板颗粒膜蛋白(GMP-140)和D一二聚体(DD).结果肺心病患者VWF、F1+2、Fg、GMP-140、DD血浆浓度显著高于对照组;肺心病治疗组经LMWH治疗后上述各凝血分子标记物及PaCO2明显降低,而PaO2显著增高,常规组虽血气指标略有改善,但凝血分子标记物未见改善.结论尽早检测肺心病血栓前状态,及时给予低分子肝素抗凝干预,有望从根本上改善肺心病急性加重期患者的不良预后。

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

目的 探讨肺心病患者的血栓前状态,观察并分析低分子肝素抗凝干预的疗效.方法将54例肺心病患者分为低分子肝素治疗组和常规治疗组各27例,分别检测治疗前后血浆血管性假血友病因子(VWF)、血浆凝血酶片段1+2(F1+2)、纤维蛋白原(Fg)、血小板颗粒膜蛋白(GMP-140)和D一二聚体(DD).结果肺心病患者VWF、F1+2、Fg、GMP-140、DD血浆浓度显著高于对照组;肺心病治疗组经LMWH治疗后上述各凝血分子标记物及PaCO2明显降低,而PaO2显著增高,常规组虽血气指标略有改善,但凝血分子标记物未见改善.结论尽早检测肺心病血栓前状态,及时给予低分子肝素抗凝干预,有望从根本上改善肺心病急性加重期患者的不良预后。

Key concepts: Thrombosis, Medicine, Anticoagulant, Cardiology, Anticoagulant therapy, Internal medicine, Pulmonary embolism, Intensive care medicine

Related papers

Back to paper searchBrowse research topicsOriginal source
A Clinical Study on the Anticoagulant Treatment of Pre-thrombosis State in Patients with Cor Pulmonale — Research Paper | ScholarLens